RU2465812C2 - Система детектирования аномального выходного сигнала для биосенсора - Google Patents
Система детектирования аномального выходного сигнала для биосенсора Download PDFInfo
- Publication number
- RU2465812C2 RU2465812C2 RU2008148133/14A RU2008148133A RU2465812C2 RU 2465812 C2 RU2465812 C2 RU 2465812C2 RU 2008148133/14 A RU2008148133/14 A RU 2008148133/14A RU 2008148133 A RU2008148133 A RU 2008148133A RU 2465812 C2 RU2465812 C2 RU 2465812C2
- Authority
- RU
- Russia
- Prior art keywords
- pulse
- input signal
- output signal
- polling
- analyzed
- Prior art date
Links
- 238000001514 detection method Methods 0.000 title claims abstract description 41
- 230000002159 abnormal effect Effects 0.000 title claims abstract description 39
- 239000013060 biological fluid Substances 0.000 claims abstract description 54
- 238000000034 method Methods 0.000 claims abstract description 51
- 230000004044 response Effects 0.000 claims abstract description 41
- 238000005259 measurement Methods 0.000 claims abstract description 23
- 230000007704 transition Effects 0.000 claims abstract 3
- 239000012491 analyte Substances 0.000 claims description 76
- 238000004458 analytical method Methods 0.000 claims description 57
- 238000006479 redox reaction Methods 0.000 claims description 32
- 238000004082 amperometric method Methods 0.000 claims description 17
- 239000008280 blood Substances 0.000 claims description 15
- 210000004369 blood Anatomy 0.000 claims description 15
- 238000010606 normalization Methods 0.000 claims description 7
- 238000007619 statistical method Methods 0.000 claims description 6
- 238000004891 communication Methods 0.000 claims description 5
- 238000000926 separation method Methods 0.000 claims 1
- 239000000126 substance Substances 0.000 abstract description 17
- 230000033116 oxidation-reduction process Effects 0.000 abstract description 3
- 238000012360 testing method Methods 0.000 abstract description 3
- 239000003814 drug Substances 0.000 abstract description 2
- 230000001143 conditioned effect Effects 0.000 abstract 2
- 230000003750 conditioning effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000007274 generation of a signal involved in cell-cell signaling Effects 0.000 abstract 1
- 238000002347 injection Methods 0.000 abstract 1
- 239000007924 injection Substances 0.000 abstract 1
- 239000000523 sample Substances 0.000 description 121
- 230000003287 optical effect Effects 0.000 description 17
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 15
- 239000008103 glucose Substances 0.000 description 15
- 239000004020 conductor Substances 0.000 description 12
- 239000002245 particle Substances 0.000 description 10
- 108090000790 Enzymes Proteins 0.000 description 8
- 102000004190 Enzymes Human genes 0.000 description 8
- 239000003153 chemical reaction reagent Substances 0.000 description 8
- 229940088598 enzyme Drugs 0.000 description 8
- 230000003647 oxidation Effects 0.000 description 8
- 238000007254 oxidation reaction Methods 0.000 description 8
- 238000004832 voltammetry Methods 0.000 description 7
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 239000012530 fluid Substances 0.000 description 6
- 238000006722 reduction reaction Methods 0.000 description 6
- 238000004364 calculation method Methods 0.000 description 5
- 230000009467 reduction Effects 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 206010000117 Abnormal behaviour Diseases 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000007795 chemical reaction product Substances 0.000 description 4
- 238000003869 coulometry Methods 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 238000005534 hematocrit Methods 0.000 description 4
- 210000003296 saliva Anatomy 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- 210000002700 urine Anatomy 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 3
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 3
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 3
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- 238000004422 calculation algorithm Methods 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 230000000875 corresponding effect Effects 0.000 description 3
- 238000000840 electrochemical analysis Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 229940116269 uric acid Drugs 0.000 description 3
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- 241000218691 Cupressaceae Species 0.000 description 2
- 230000002238 attenuated effect Effects 0.000 description 2
- 239000012472 biological sample Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000002596 correlated effect Effects 0.000 description 2
- 238000002848 electrochemical method Methods 0.000 description 2
- 238000001208 nuclear magnetic resonance pulse sequence Methods 0.000 description 2
- 230000000737 periodic effect Effects 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- 125000003831 tetrazolyl group Chemical group 0.000 description 2
- 108010050375 Glucose 1-Dehydrogenase Proteins 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 229960005489 paracetamol Drugs 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000013102 re-test Methods 0.000 description 1
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000027756 respiratory electron transport chain Effects 0.000 description 1
- 238000004092 self-diagnosis Methods 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 230000002277 temperature effect Effects 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/1468—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means
- A61B5/1486—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means using enzyme electrodes, e.g. with immobilised oxidase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/001—Enzyme electrodes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/28—Electrolytic cell components
- G01N27/30—Electrodes, e.g. test electrodes; Half-cells
- G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
- G01N27/3271—Amperometric enzyme electrodes for analytes in body fluids, e.g. glucose in blood
- G01N27/3273—Devices therefor, e.g. test element readers, circuitry
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B5/00—ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
- G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
- G16C20/10—Analysis or design of chemical reactions, syntheses or processes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medical Informatics (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Surgery (AREA)
- Organic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Optics & Photonics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Theoretical Computer Science (AREA)
- Bioinformatics & Computational Biology (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Evolutionary Biology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Emergency Medicine (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Electrochemistry (AREA)
- Physiology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US74677106P | 2006-05-08 | 2006-05-08 | |
| US60/746,771 | 2006-05-08 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2008148133A RU2008148133A (ru) | 2010-06-20 |
| RU2465812C2 true RU2465812C2 (ru) | 2012-11-10 |
Family
ID=38543641
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2008148133/14A RU2465812C2 (ru) | 2006-05-08 | 2007-05-07 | Система детектирования аномального выходного сигнала для биосенсора |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US8234076B2 (enExample) |
| EP (1) | EP2020909A2 (enExample) |
| JP (2) | JP5121822B2 (enExample) |
| CN (1) | CN101437443B (enExample) |
| BR (1) | BRPI0711433A2 (enExample) |
| CA (1) | CA2650880C (enExample) |
| MX (1) | MX2008014250A (enExample) |
| NO (1) | NO20084960L (enExample) |
| RU (1) | RU2465812C2 (enExample) |
| TW (1) | TWI431273B (enExample) |
| WO (1) | WO2007133985A2 (enExample) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3172559B2 (ja) | 1991-11-20 | 2001-06-04 | 株式会社クラレ | 艶消しフィルム |
| BRPI0507376A (pt) | 2004-02-06 | 2007-07-10 | Bayer Healthcare Llc | espécie oxidável como uma referência interna para biossensores e método de uso |
| US8529751B2 (en) | 2006-03-31 | 2013-09-10 | Lifescan, Inc. | Systems and methods for discriminating control solution from a physiological sample |
| US7966859B2 (en) | 2006-05-03 | 2011-06-28 | Bayer Healthcare Llc | Underfill detection system for a biosensor |
| WO2007133995A2 (en) | 2006-05-08 | 2007-11-22 | The Lubrizol Corporation | Lubricating composition containing a polymer and antiwear agents |
| BRPI0711433A2 (pt) * | 2006-05-08 | 2011-11-16 | Bayer Healthcare Llc | sistema de detecção de saìda anormal para um biosensor |
| US8778168B2 (en) | 2007-09-28 | 2014-07-15 | Lifescan, Inc. | Systems and methods of discriminating control solution from a physiological sample |
| WO2009076302A1 (en) | 2007-12-10 | 2009-06-18 | Bayer Healthcare Llc | Control markers for auto-detection of control solution and methods of use |
| RU2706691C2 (ru) | 2007-12-10 | 2019-11-20 | Асцензия Диабетс Кэар Холдингс АГ | Способ определения концентрации аналита |
| WO2009075951A1 (en) * | 2007-12-10 | 2009-06-18 | Bayer Healthcare Llc | Rapid-read gated amperometry |
| US8603768B2 (en) * | 2008-01-17 | 2013-12-10 | Lifescan, Inc. | System and method for measuring an analyte in a sample |
| US8551320B2 (en) | 2008-06-09 | 2013-10-08 | Lifescan, Inc. | System and method for measuring an analyte in a sample |
| BRPI0923342A2 (pt) | 2008-12-08 | 2016-01-12 | Bayer Healthcare Llc | sistema biosensor com ajuste de sinal |
| DE102009048811B4 (de) * | 2009-10-08 | 2013-07-18 | Eads Deutschland Gmbh | Biosensorvorrichtung mit Selbsttesteinrichtung |
| CA2793878C (en) | 2010-03-22 | 2018-09-11 | Bayer Healthcare Llc | Residual compensation for a biosensor |
| BR112012031166A2 (pt) * | 2010-06-07 | 2018-02-27 | Bayer Healthcare Llc | compensação baseada eminclinação incluindo sinais de saída secundários |
| CN103038636B (zh) * | 2010-06-07 | 2015-01-14 | 拜尔健康护理有限责任公司 | 用于生物传感器的未充满管理系统 |
| US8923918B2 (en) * | 2010-12-18 | 2014-12-30 | Kallows Engineering India Pvt. Ltd. | Biosensor interface apparatus for a mobile communication device |
| US9008744B2 (en) | 2011-05-06 | 2015-04-14 | Medtronic Minimed, Inc. | Method and apparatus for continuous analyte monitoring |
| KR20140063829A (ko) | 2011-09-21 | 2014-05-27 | 바이엘 헬쓰케어, 엘엘씨 | 오차 보상을 갖는 바이오센서 |
| US9810688B2 (en) * | 2013-03-15 | 2017-11-07 | Robert Bosch Gmbh | Smart glass slide for microarrays |
| US9005426B2 (en) | 2012-09-28 | 2015-04-14 | Cilag Gmbh International | System and method for determining hematocrit insensitive glucose concentration |
| US9080196B2 (en) * | 2012-09-28 | 2015-07-14 | Cilag Gmbh International | System and method for determining hematocrit insensitive glucose concentration |
| US9958410B2 (en) * | 2013-03-14 | 2018-05-01 | Ascensia Diabetes Care Holdings Ag | Normalized calibration of analyte concentration determinations |
| CN105283757B (zh) * | 2013-03-15 | 2019-04-23 | 豪夫迈·罗氏有限公司 | 对分析物的电化学测量进行防故障的方法以及结合该方法的设备、装置和系统 |
| KR101743382B1 (ko) * | 2013-03-15 | 2017-06-02 | 에프. 호프만-라 로슈 아게 | 전기화학적 측정 중 높은 항산화제 레벨들을 검출하고 그로부터 분석물질 농도를 페일세이프하는 방법들 뿐만 아니라 상기 방법들을 통합한 기기들, 장치들 및 시스템들 |
| CN104122882A (zh) * | 2013-04-24 | 2014-10-29 | 中烟机械技术中心有限责任公司 | 巴鲁夫自诊断型传感器的故障诊断系统 |
| TWI567387B (zh) | 2014-09-12 | 2017-01-21 | 達爾生技股份有限公司 | 電化學的感測試片本身性質之異常的檢測方法 |
| CN105445341B (zh) * | 2014-09-12 | 2018-10-16 | 达尔生技股份有限公司 | 电化学的检测试片异常的检测方法 |
| JP7062954B2 (ja) * | 2016-02-10 | 2022-05-09 | ソニーグループ株式会社 | 血液凝固解析装置及び血液凝固解析方法 |
| EP3548881A1 (en) * | 2016-12-05 | 2019-10-09 | Ascensia Diabetes Care Holdings AG | Risk factor monitoring |
| KR102031340B1 (ko) * | 2018-03-14 | 2019-10-11 | 주식회사 필로시스 | 혈당 측정 장치, 방법, 및 시스템 |
| US11382541B2 (en) | 2018-11-16 | 2022-07-12 | Medtronic Minimed, Inc. | Miniaturized analyte sensor |
| CN112305040B (zh) * | 2019-08-02 | 2023-10-31 | 华广生技股份有限公司 | 植入式微型生物传感器及其操作方法 |
| TWI870545B (zh) * | 2020-02-21 | 2025-01-21 | 美商半導體組件工業公司 | 用於測量工作電極電流之方法、雙向恆電位器、及電池測量系統 |
| CN111681713B (zh) * | 2020-06-10 | 2023-03-31 | 重庆邮电大学 | 一种包含退相干作用的聚合物分子电学性质的模型构建方法及其应用 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5243516A (en) * | 1989-12-15 | 1993-09-07 | Boehringer Mannheim Corporation | Biosensing instrument and method |
| RU2232608C2 (ru) * | 1998-11-02 | 2004-07-20 | Элзэ Копэрейшн | Устройство для чрескожной доставки лекарственного средства электропереносом и способ его изготовления, способ чрескожной доставки лекарственного средства пациенту электропереносом |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4431004A (en) | 1981-10-27 | 1984-02-14 | Bessman Samuel P | Implantable glucose sensor |
| US4750496A (en) | 1987-01-28 | 1988-06-14 | Xienta, Inc. | Method and apparatus for measuring blood glucose concentration |
| US5508171A (en) | 1989-12-15 | 1996-04-16 | Boehringer Mannheim Corporation | Assay method with enzyme electrode system |
| FR2701117B1 (fr) | 1993-02-04 | 1995-03-10 | Asulab Sa | Système de mesures électrochimiques à capteur multizones, et son application au dosage du glucose. |
| US5366609A (en) | 1993-06-08 | 1994-11-22 | Boehringer Mannheim Corporation | Biosensing meter with pluggable memory key |
| IE72524B1 (en) * | 1994-11-04 | 1997-04-23 | Elan Med Tech | Analyte-controlled liquid delivery device and analyte monitor |
| US6153069A (en) * | 1995-02-09 | 2000-11-28 | Tall Oak Ventures | Apparatus for amperometric Diagnostic analysis |
| US5582697A (en) | 1995-03-17 | 1996-12-10 | Matsushita Electric Industrial Co., Ltd. | Biosensor, and a method and a device for quantifying a substrate in a sample liquid using the same |
| US5620579A (en) * | 1995-05-05 | 1997-04-15 | Bayer Corporation | Apparatus for reduction of bias in amperometric sensors |
| DK0958495T3 (da) * | 1997-02-06 | 2003-03-10 | Therasense Inc | In vitro analysand sensor med lille volumen |
| US6391645B1 (en) | 1997-05-12 | 2002-05-21 | Bayer Corporation | Method and apparatus for correcting ambient temperature effect in biosensors |
| AU3849799A (en) | 1998-05-20 | 1999-12-06 | Arkray, Inc. | Method and apparatus for electrochemical measurement using statistical technique |
| CA2305922C (en) | 1999-08-02 | 2005-09-20 | Bayer Corporation | Improved electrochemical sensor design |
| GB0005564D0 (en) * | 2000-03-08 | 2000-05-03 | Inverness Medical Ltd | Measurjement of substances in liquid |
| WO2003082098A2 (en) * | 2002-03-22 | 2003-10-09 | Cygnus, Inc. | Improving performance of an analyte monitoring device |
| KR100808225B1 (ko) * | 2003-05-05 | 2008-02-29 | 인벤텍 어플라이언스 코포레이션 | 핸드헬드 계산 장치에서 아날로그 신호를 생성하기 위한시스템 및 방법 |
| US7488601B2 (en) * | 2003-06-20 | 2009-02-10 | Roche Diagnostic Operations, Inc. | System and method for determining an abused sensor during analyte measurement |
| EP1751532A1 (en) * | 2004-05-14 | 2007-02-14 | Bayer Healthcare, LLC | Methods for performing hematocrit adjustment in glucose assays and devices for same |
| KR101503072B1 (ko) * | 2005-07-20 | 2015-03-16 | 바이엘 헬스케어 엘엘씨 | 게이트형 전류 측정법 |
| CA2986870A1 (en) * | 2005-09-30 | 2007-04-12 | Ascensia Diabetes Care Holdings Ag | Gated voltammetry |
| BRPI0711433A2 (pt) * | 2006-05-08 | 2011-11-16 | Bayer Healthcare Llc | sistema de detecção de saìda anormal para um biosensor |
-
2007
- 2007-05-07 BR BRPI0711433-8A patent/BRPI0711433A2/pt not_active IP Right Cessation
- 2007-05-07 JP JP2009510115A patent/JP5121822B2/ja active Active
- 2007-05-07 EP EP07783344A patent/EP2020909A2/en not_active Ceased
- 2007-05-07 WO PCT/US2007/068320 patent/WO2007133985A2/en not_active Ceased
- 2007-05-07 CN CN2007800162447A patent/CN101437443B/zh active Active
- 2007-05-07 TW TW096116094A patent/TWI431273B/zh not_active IP Right Cessation
- 2007-05-07 RU RU2008148133/14A patent/RU2465812C2/ru active
- 2007-05-07 CA CA2650880A patent/CA2650880C/en not_active Expired - Fee Related
- 2007-05-07 MX MX2008014250A patent/MX2008014250A/es active IP Right Grant
-
2008
- 2008-10-17 US US12/253,440 patent/US8234076B2/en active Active
- 2008-11-26 NO NO20084960A patent/NO20084960L/no not_active Application Discontinuation
-
2012
- 2012-06-28 US US13/536,310 patent/US9301717B2/en active Active
- 2012-08-21 JP JP2012182103A patent/JP5373948B2/ja active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5243516A (en) * | 1989-12-15 | 1993-09-07 | Boehringer Mannheim Corporation | Biosensing instrument and method |
| RU2232608C2 (ru) * | 1998-11-02 | 2004-07-20 | Элзэ Копэрейшн | Устройство для чрескожной доставки лекарственного средства электропереносом и способ его изготовления, способ чрескожной доставки лекарственного средства пациенту электропереносом |
Non-Patent Citations (1)
| Title |
|---|
| BOLLI "The Problem of Hypoglicemia in intensive as well as nonintensive Treatmtnt…", Diabetes Care, 22, 1999, s.2, 1343-1352. * |
Also Published As
| Publication number | Publication date |
|---|---|
| US9301717B2 (en) | 2016-04-05 |
| TW200804805A (en) | 2008-01-16 |
| US8234076B2 (en) | 2012-07-31 |
| EP2020909A2 (en) | 2009-02-11 |
| JP5121822B2 (ja) | 2013-01-16 |
| JP5373948B2 (ja) | 2013-12-18 |
| MX2008014250A (es) | 2008-11-26 |
| WO2007133985A3 (en) | 2008-01-10 |
| US20090099787A1 (en) | 2009-04-16 |
| HK1132643A1 (en) | 2010-03-05 |
| JP2009536744A (ja) | 2009-10-15 |
| CA2650880C (en) | 2015-11-24 |
| US20120271559A1 (en) | 2012-10-25 |
| JP2012255803A (ja) | 2012-12-27 |
| BRPI0711433A2 (pt) | 2011-11-16 |
| CN101437443A (zh) | 2009-05-20 |
| WO2007133985A2 (en) | 2007-11-22 |
| NO20084960L (no) | 2008-11-26 |
| CN101437443B (zh) | 2011-11-30 |
| CA2650880A1 (en) | 2007-11-22 |
| RU2008148133A (ru) | 2010-06-20 |
| TWI431273B (zh) | 2014-03-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2465812C2 (ru) | Система детектирования аномального выходного сигнала для биосенсора | |
| RU2441223C2 (ru) | Система обнаружения состояния недостаточного заполнения для электрохимического биосенсора | |
| US10724985B2 (en) | Biosensor for determining a concentration of a biosensor using an underfill procedure | |
| JP6448504B2 (ja) | 勾配ベース補正 | |
| KR20120099452A (ko) | 바이오센서용 언더필 인식 시스템 | |
| CN101842695A (zh) | 质控液的判别方法以及分析装置 | |
| HK1132643B (en) | Abnormal output detection system for a biosensor | |
| HK1133080B (en) | Underfill detection system for an electrochemical biosensor |